A review on potential of PARP inhibitors in the treatment of prostate cancer

A review on potential of PARP inhibitors in the treatment of prostate cancer

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.

Sonraí bibleagrafaíochta
Príomhchruthaitheoir:	Islam, Saidul
Rannpháirtithe:	Sharmin, Shahana
Formáid:	Tráchtas
Teanga:	English
Foilsithe / Cruthaithe:	Brac University 2022
Ábhair:	Prostate cancer Therapeutic approaches mCRPC PARP inhibitors Olaparib Cancer > Treatment Enzyme inhibitors > Therapeutic use Cancer > Gene therapy
Rochtain ar líne:	http://hdl.handle.net/10361/17308

Míreanna comhchosúla

A review on newly approved PARP inhibitors: Talazoparib and Olaparib
de réir: Karim, Azrin
Foilsithe / Cruthaithe: (2024)

Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
de réir: Flora, Sanzida Alam
Foilsithe / Cruthaithe: (2024)

SHP2 inhibitors: Recent advancements and potential breakthroughs in cancer therapy
de réir: Meem, Manila
Foilsithe / Cruthaithe: (2023)

Benign Prostatic Hyperplasia & Prostate Cancer: a review on the treatment strategies
de réir: Alam, Tahera
Foilsithe / Cruthaithe: (2024)

RIPK pathway, as a potential target, for cancer treatment - a review
de réir: Jahan, Nusrat
Foilsithe / Cruthaithe: (2024)

Association of XRCC1 and XPD polymorphism with risk of prostate cancer in Bangladesh population
de réir: Ahmed, Nafisa
Foilsithe / Cruthaithe: (2023)

Immunotherapy in the Management of Lung Cancer
de réir: Tasnim, Humayra
Foilsithe / Cruthaithe: (2022)

A review on triple-negative breast cancer and its potential treatment
de réir: Niasa, Jannatul Ferdous
Foilsithe / Cruthaithe: (2023)

Stem cells as therapeutic carrier in cancer treatment
de réir: Anika, Mysha Yeasmin
Foilsithe / Cruthaithe: (2022)

An examination of therapeutic synergy: a comprehensive meta-analysis comparing the efficacy of TAS-102 and FOLFOX as a combination therapy for colon cancer
de réir: Hasan, Amit
Foilsithe / Cruthaithe: (2024)

Drug repurposing: potential of Antimicrobial Drugs in Breast Cancer Treatment
de réir: Chakraborty, Anuradha
Foilsithe / Cruthaithe: (2024)

A review on Bruton's Tyrosine Kinase inhibitors to outline the scopes of further advancements in the treatment of cancer
de réir: Khan, Muidul Hasan
Foilsithe / Cruthaithe: (2024)

A review on potential role of cannabinoids as therapeutic agents in different types of cancer
de réir: Roy, Hredita
Foilsithe / Cruthaithe: (2018)

Recent advances in Cancer treatment targeting autophagy and future aspects
de réir: Emon, Kamrul Hasan
Foilsithe / Cruthaithe: (2022)

Tamoxifen: The ideal post operative hormonal therapy to demote Ductal Carcinoma in Situ
de réir: Mirza, Maisa Tasnim
Foilsithe / Cruthaithe: (2023)

Role of toll-like receptors in cancer immunotherapy– a review
de réir: Khan, Rezia Nowrin
Foilsithe / Cruthaithe: (2021)

In silico analysis revealed hsa-miR-19a-3p and hsa-miR-19b-3p as two potential inhibitors of EGF mRNA in Breast Cancer
de réir: Nuha, Nabiha Tahsin
Foilsithe / Cruthaithe: (2024)

Role of statins as antagonists of SPARC in gastric cancer
de réir: Shahmat, Rad
Foilsithe / Cruthaithe: (2019)

A review on cyclin-dependent kinase 7 (CDK7) Inhibitors as anticancer agents
de réir: Sorno, Rubina Haque
Foilsithe / Cruthaithe: (2024)

A review of next-generation immuno-oncology agents for cancer therapy: recent dictation shifts in cancer immunotherapy
de réir: Ratu, Tabassum
Foilsithe / Cruthaithe: (2024)

A review on bispecific antibody (blinatumomab) for the treatment of acute lymphoblastic leukemia
de réir: Choki, Kinley
Foilsithe / Cruthaithe: (2024)

Recent developments in the Adeno-Associated Viral Gene Therapy for Non-Small Cell Lung Cancer during the past 20 years
de réir: Razna, Amrin Islam
Foilsithe / Cruthaithe: (2019)

A comprehensive review on drug repurposing in cancer treatment
de réir: Sarkar, Onusree
Foilsithe / Cruthaithe: (2024)

A review on RNAi technology and its therapeutic potential in Cancer
de réir: Mahaleka, Aarshi
Foilsithe / Cruthaithe: (2024)

Prevalence and application of an evolving genome editing tool “CRISPR/Cas System” in cancer research and treatment
de réir: Shaikat, Mahdi Mubin
Foilsithe / Cruthaithe: (2023)

Genetic innovations for breast cancer treatment : a review of gene therapy strategies and future implications
de réir: Hasan, Sakib
Foilsithe / Cruthaithe: (2024)

Survey on patients undergoing treatments for cervical, endometrial and ovarian cancer
de réir: Nawar, Anika
Foilsithe / Cruthaithe: (2019)

Statistics and informatics in molecular cancer research

Identification of FAP inhibitors using in silico simulation study
de réir: Deeba, Maliha Tasnim
Foilsithe / Cruthaithe: (2018)

Targeting BRAFV600E in the treatment of CRC
de réir: Roja, Mashwiyat Samrin
Foilsithe / Cruthaithe: (2024)

Targeted therapeutic options in the treatment of Breast Cancer
de réir: Alam, Kazi Tasnuva
Foilsithe / Cruthaithe: (2022)

Clinical outcomes and safety comparison of gemcitabine plus cisplatin, capecitabine monotherapy, and gemcitabine plus oxaliplatin in the management of gallbladder carcinoma: a comprehensive meta-analysis
de réir: Rahman, Sanjida
Foilsithe / Cruthaithe: (2024)

Biosimilar in lymphoma treatment
de réir: Tanisha, Mehrin Haque
Foilsithe / Cruthaithe: (2021)

Current practice and approaches of immunotherapy in Cancer treatment
de réir: Khondokar, Faiza
Foilsithe / Cruthaithe: (2022)

A pharmacovigilance study on FDA approved interleukin inhibitor-associated alopecia in the treatment of psoriasis
de réir: Islam, Nahidul
Foilsithe / Cruthaithe: (2023)

A review on Single Nucleotide Polymorphism (SNPs) and their effect on cancer risk in South Asian population
de réir: Beruni, Sajid Mahmud Al
Foilsithe / Cruthaithe: (2022)

Oncogenes: new targets in cancer treatment
de réir: Chowdhury, Waseka Shams
Foilsithe / Cruthaithe: (2020)

Potential phytochemicals and dietary components for the prevention and treatment of skin cancer: A review
de réir: Muntaha, Habibatul
Foilsithe / Cruthaithe: (2023)

A review of comparison on efficacy, safety and cost effectiveness of cholinesterase inhibitors, NMDA antagonists and combination therapy in the treatment of Alzheimer’s disease
de réir: Haque, Mushfiqul
Foilsithe / Cruthaithe: (2019)

Pooled analysis of response rate and overall survival of Tyrosine Kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
de réir: Karim, Samia Binte
Foilsithe / Cruthaithe: (2024)